138 related articles for article (PubMed ID: 1524802)
1. Carcinoma-associated monoclonal antibodies in head and neck carcinoma. Immunohistochemistry and biodistribution of monoclonal antibodies 175F4 and 175F11.
Balm AJ; Hageman PC; Mulder CL; Hilkens J
Eur Arch Otorhinolaryngol; 1992; 249(5):237-42. PubMed ID: 1524802
[TBL] [Abstract][Full Text] [Related]
2. Detection of squamous cell carcinoma xenografts in nude mice by radiolabeled monoclonal antibody E48.
Quak JJ; Gerretsen M; Schrijvers AH; Meijer CJ; van Dongen GA; Snow GB
Arch Otolaryngol Head Neck Surg; 1991 Nov; 117(11):1287-91. PubMed ID: 1747235
[TBL] [Abstract][Full Text] [Related]
3. Superior localisation and imaging of radiolabelled monoclonal antibody E48 F(ab')2 fragment in xenografts of human squamous cell carcinoma of the head and neck and of the vulva as compared to monoclonal antibody E48 IgG.
Gerretsen M; Quak JJ; Suh JS; van Walsum M; Meijer CJ; Snow GB; van Dongen GA
Br J Cancer; 1991 Jan; 63(1):37-44. PubMed ID: 1989663
[TBL] [Abstract][Full Text] [Related]
4. A novel CD44v6 targeting antibody fragment with improved tumor-to-blood ratio.
Sandström K; Haylock AK; Spiegelberg D; Qvarnström F; Wester K; Nestor M
Int J Oncol; 2012 May; 40(5):1525-32. PubMed ID: 22307465
[TBL] [Abstract][Full Text] [Related]
5. Development of monoclonal antibodies with specificity to oral squamous cell carcinoma.
Fantozzi RD
Laryngoscope; 1991 Oct; 101(10):1076-80. PubMed ID: 1921634
[TBL] [Abstract][Full Text] [Related]
6. MAb U36, a novel monoclonal antibody successful in immunotargeting of squamous cell carcinoma of the head and neck.
Schrijvers AH; Quak JJ; Uyterlinde AM; van Walsum M; Meijer CJ; Snow GB; van Dongen GA
Cancer Res; 1993 Sep; 53(18):4383-90. PubMed ID: 8364934
[TBL] [Abstract][Full Text] [Related]
7. Perspectives of monoclonal antibodies for detection and treatment of head and neck tumours.
Quak J; Gerretsen M; De Bree R; Brakenhof R; Van Dongen G; Snow G
Anticancer Res; 1993; 13(6B):2533-9. PubMed ID: 8135493
[TBL] [Abstract][Full Text] [Related]
8. Rapid elimination of mouse/human chimeric monoclonal antibodies in nude mice.
van Gog FB; Brakenhoff RH; Snow GB; van Dongen GA
Cancer Immunol Immunother; 1997 Apr; 44(2):103-11. PubMed ID: 9177472
[TBL] [Abstract][Full Text] [Related]
9. Experimental and clinical analysis of the characteristics of a chimeric monoclonal antibody, MOv18, reactive with an ovarian cancer-associated antigen.
Molthoff CF; Buist MR; Kenemans P; Pinedo HM; Boven E
J Nucl Med; 1992 Nov; 33(11):2000-5. PubMed ID: 1432162
[TBL] [Abstract][Full Text] [Related]
10. [A monoclonal antibody reactive with human squamous cell carcinoma of the esophagus].
Tomita Y
Nihon Geka Gakkai Zasshi; 1994 Jul; 95(7):425-34. PubMed ID: 7520969
[TBL] [Abstract][Full Text] [Related]
11. Murine monoclonal antibodies raised against human non-small cell carcinoma of the lung: specificity and tumor targeting.
Stein R; Chen S; Sharkey RM; Goldenberg DM
Cancer Res; 1990 Feb; 50(4):1330-6. PubMed ID: 2153458
[TBL] [Abstract][Full Text] [Related]
12. Early response monitoring with 18F-FDG PET and cetuximab-F(ab')2-SPECT after radiotherapy of human head and neck squamous cell carcinomas in a mouse model.
van Dijk LK; Boerman OC; Franssen GM; Lok J; Kaanders JH; Bussink J
J Nucl Med; 2014 Oct; 55(10):1665-70. PubMed ID: 25236350
[TBL] [Abstract][Full Text] [Related]
13. [Monoclonal antibody UW 21/123: clinical use and diagnostic specificity in head and neck cancers].
Zenner HP; Herrmann IF; Moser L
Laryngol Rhinol Otol (Stuttg); 1986 May; 65(5):287-91. PubMed ID: 3016433
[TBL] [Abstract][Full Text] [Related]
14. 111In-cetuximab-F(ab')2 SPECT and 18F-FDG PET for prediction and response monitoring of combined-modality treatment of human head and neck carcinomas in a mouse model.
van Dijk LK; Boerman OC; Franssen GM; Kaanders JH; Bussink J
J Nucl Med; 2015 Feb; 56(2):287-92. PubMed ID: 25552666
[TBL] [Abstract][Full Text] [Related]
15. Targeting CD44v6 expressed in head and neck squamous cell carcinoma: preclinical characterization of an 111In-labeled monoclonal antibody.
Sandström K; Nestor M; Ekberg T; Engström M; Anniko M; Lundqvist H
Tumour Biol; 2008; 29(3):137-44. PubMed ID: 18612218
[TBL] [Abstract][Full Text] [Related]
16. 44-kd oncofetal transplantation antigen in rodent and human fetal cells. Implications of recrudescence in human and rodent cancers.
Coggin JH; Rohrer SD; Hester RD; Barsoum AL; Rashid HU; Gussack GS
Arch Otolaryngol Head Neck Surg; 1993 Nov; 119(11):1257-66. PubMed ID: 8217085
[TBL] [Abstract][Full Text] [Related]
17. Production of a monoclonal antibody (K 931) to a squamous cell carcinoma associated antigen identified as the 17-1A antigen.
Quak JJ; Van Dongen G; Brakkee JG; Hayashida DJ; Balm AJ; Snow GB; Meijer CJ
Hybridoma; 1990 Aug; 9(4):377-87. PubMed ID: 2210778
[TBL] [Abstract][Full Text] [Related]
18. Localization and imaging of radiolabelled monoclonal antibody against squamous-cell carcinoma of the head and neck in tumor-bearing nude mice.
Quak JJ; Balm AJ; Brakkee JG; Scheper RJ; Haisma HJ; Braakhuis BJ; Meijer CJ; Snow GB
Int J Cancer; 1989 Sep; 44(3):534-8. PubMed ID: 2777416
[TBL] [Abstract][Full Text] [Related]
19. [Possibilities for using monoclonal antibodies in diagnosis and therapy of head and neck cancers. I. Introduction and current state].
Wustrow TP
HNO; 1991 Mar; 39(3):82-90. PubMed ID: 2050556
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the pharmacokinetics, biodistribution and dosimetry of monoclonal antibodies OC125, OV-TL 3, and 139H2 as IgG and F(ab')2 fragments in experimental ovarian cancer.
Molthoff CF; Pinedo HM; Schlüper HM; Nijman HW; Boven E
Br J Cancer; 1992 May; 65(5):677-83. PubMed ID: 1586596
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
